Bullous pemphigoid treated with mycophenolate mofetil. 1997

M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D010391 Pemphigoid, Bullous A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis. Pemphigoid,Bullous Pemphigoid,Pemphigoids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
September 1998, Journal of the American Academy of Dermatology,
M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
August 2015, Dermatology online journal,
M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
January 2010, Pediatric dermatology,
M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
June 1999, Archives of dermatology,
M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
January 2008, Skinmed,
M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
October 2001, Singapore medical journal,
M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
October 2012, The Journal of dermatology,
M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
February 2022, Journal of drugs in dermatology : JDD,
M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
January 2005, Annales de dermatologie et de venereologie,
M Böhm, and S Beissert, and T Schwarz, and D Metze, and T Luger
January 2015, Case reports in gastrointestinal medicine,
Copied contents to your clipboard!